Workflow
Perfect(603059)
icon
Search documents
倍加洁:倍加洁集团股份有限公司2024年第一次临时股东会会议资料
2024-09-06 08:35
股东会会议资料 倍加洁集团股份有限公司 PERFECT GROUP CORP.,LTD (江苏省扬州市杭集工业园) 2024 年第一次临时股东会 会议资料 1 股东会会议资料 2024 年第一次临时股东会会议须知 为了维护广大投资者的合法权益,确保股东会的正常秩序和议事效率,根 据《中华人民共和国公司法》(以下简称"《公司法》")、《上海证券交易所股 票上市规则》(以下简称"《股票上市规则》")及《倍加洁集团股份有限公司章程》 (以下简称"《公司章程》")等相关法律、法规及规范性文件,制定本须知, 请出席股东会的全体人员自觉遵守。 1、本次会议设会务组,由公司董事会秘书负责会议的程序安排和会务工作。 2、为保证本次会议的严肃性和正常秩序,切实维护股东的合法权益,务必 请出席会议的股东或股东代理人(以下统称"股东")及相关人员准时到达会场 签到确认参会资格。股东在参会登记时间内没有通过传真或书面信函方式登记 的,不在签到表上登记签到的,或会议正式开始后没有统计在会议公布股权数之 内的股东或代理人,不得参加表决。 3、出席会议的股东(或股东代理人)依法享有发言权、表决权等各项权利, 并履行法定义务和遵守相关规则。 ...
倍加洁:内生外延齐头并举
Tianfeng Securities· 2024-09-03 13:08
Investment Rating - The investment rating for the company is "Buy" with a target price set at 20.34 CNY, maintaining the rating for the next six months [2]. Core Insights - The company reported a revenue of 330 million CNY in Q2 2024, representing a year-on-year increase of 28.9%. However, the net profit attributable to the parent company decreased by 51.7% to 14 million CNY [2]. - For the first half of 2024, the company achieved a revenue of 620 million CNY, up 28.6% year-on-year, while the net profit attributable to the parent company was 33 million CNY, down 9.4% [2]. - The growth in revenue is attributed to increased sales of oral care products and the addition of probiotic sales from a recent acquisition [2]. - The company has a production capacity of 672 million toothbrushes and 18 billion wet wipes annually, holding significant positions in the oral care and disposable hygiene products sectors [5]. Financial Performance - In H1 2024, the toothbrush segment generated 250 million CNY in revenue, a 20.2% increase, accounting for 40.4% of total revenue. The wet wipes segment generated 200 million CNY, up 32.6%, making up 32.2% of total revenue [2]. - The company's gross margin for H1 2024 was 25.3%, an increase of 2.6 percentage points year-on-year, while the net profit margin was 5.3%, down 2.2 percentage points [2]. - The company’s international revenue reached 380 million CNY in H1 2024, a significant increase of 112% year-on-year, representing 61.6% of total revenue, while domestic revenue was 240 million CNY, down 21.2% [2]. Industry Overview - The oral care industry in China is projected to grow at a compound annual growth rate (CAGR) of 3.75% from 2023 to 2028, with rapid development in new categories such as mouth sprays and electric toothbrushes [3]. - The wet wipes market in China has shown consistent growth, increasing from 6.74 billion CNY in 2017 to 11.6 billion CNY in 2023, with an expected CAGR of 9.46% [3]. - The probiotic market in China reached a scale of 118.85 billion CNY in 2023, with a CAGR of 11.8% from 2019 to 2023, and is expected to continue growing steadily [3]. Strategic Developments - The company is pursuing both organic growth and external expansion strategies. In April 2024, it acquired a 52% stake in a company named Shan'enkang, which will be consolidated into its financial statements [4]. - The company’s subsidiary, Nanjing Lunjie, successfully bid for a 1.59% stake in Weimeizi, which will increase its total ownership to approximately 33.9%, enhancing supply chain collaboration [4]. Earnings Forecast - The earnings forecast for the company has been adjusted, with expected net profits for 2024, 2025, and 2026 projected at 110 million CNY, 140 million CNY, and 190 million CNY respectively [5][6].
倍加洁:2024年半年报点评:口腔护理主业稳健增长,投资收益影响利润表现
Guoyuan Securities· 2024-09-03 00:13
Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook for its stock performance relative to the benchmark index [9]. Core Insights - The company's revenue for the first half of 2024 reached 620 million yuan, representing a year-on-year growth of 28.6%. However, the net profit attributable to the parent company decreased by 9.36% to 33 million yuan, primarily due to losses from an associate company [3][4]. - Excluding the impact of the associate company, the net profit for the first half of 2024 would have increased by 46.8% year-on-year [3]. - The gross margin for the first half of 2024 was 25.27%, an increase of 2.56 percentage points compared to the previous year, while the net margin decreased by 2.43 percentage points to 5.15% [3]. Revenue Breakdown - In terms of product categories, toothbrush products generated 250 million yuan in revenue, up 20.16% year-on-year, with a gross margin of 26.48%. Wet wipes achieved revenue of 199 million yuan, a growth of 32.57%, with a gross margin of 22.45% [4]. - From a business perspective, export sales amounted to 382 million yuan, a year-on-year increase of 26.48%, while domestic sales reached 238 million yuan, growing by 32.14% [4]. Strategic Developments - The company is focusing on expanding its customer base and has established partnerships with major clients such as Chongqing Dengkang, Weimeizi, Yunnan Baiyao, Watsons, Medline, and Cardinal Health [4]. - In April 2024, the company acquired a 52% stake in Shanenkang, which specializes in the full industry chain of probiotics. This acquisition is expected to contribute to the company's growth trajectory [4]. Financial Forecast - The company is projected to achieve net profits of 117 million yuan, 154 million yuan, and 181 million yuan for the years 2024, 2025, and 2026, respectively. The corresponding earnings per share (EPS) are expected to be 1.16 yuan, 1.54 yuan, and 1.80 yuan, with price-to-earnings (P/E) ratios of 17, 13, and 11 times [4][5].
倍加洁(603059) - 投资者关系活动记录表(2024年8月28日-30日)
2024-09-02 09:11
倍加洁集团股份有限公司 投资者关系活动记录表 (2024 年 8 月 28 日-30 日) 编号:2024【01】号 倍加洁集团股份有限公司(以下简称"公司")于近期以 线上电话会方式与投资者、券商分析师等进行交流,现将投 资者关系活动的主要情况发布如下: 一、投资者调研情况 (一)调研方式:线上调研 序号 日期 参加机构及人员 1 2024 年 8 月 28 日国盛轻工—倍 加洁 2024 年半 年报业绩交流会 国盛证券研究所曹馨茗、李晨;华夏基 金林瑶;衍航投资刘毅;万联证券自营 匡荣彪;明世伙伴基金唐茂钦;平安基 金叶芊;浙商自营陈姗姗;东方基金管 理股份有限公司郭晓慧;中信证券资产 管理部易杰锋;纵贯资本何诗炘;光证 资管严可人;大筝资管宋博雅;嬴昀私 募黄亚英;中信建投资管黄鹏;财通自 营简曲;华夏未来资本王月瑶;鑫元基 金张咏;广发自营牛璐;淳厚基金杨泽 宇;信泰人寿齐津;中加基金王升晖; 中信资管丁天凯;弘毅远方基金王鹏 程;汇安基金王苏煦;兴证资管陶佳恒; 国新自营孙子乾;华西基金张月宁、刘 秋宏;同犇投资余思颖;汐泰投资冯家 安;红土创新刘君杰;信泰人寿云昀; 汇泉基金王达;招商证券邓琪静、 ...
倍加洁:公司信息更新报告:主业增长稳健,参控股子公司加大投入拖累利润
KAIYUAN SECURITIES· 2024-09-01 07:40
隐证券 美容护理/个护用品 公 司 研 究 倍加洁(603059.SH) 2024 年 09 月 1 日 主业增长稳健,参控股子公司加大投入拖累利润 ——公司信息更新报告 投资评级:买入(维持) | --- | --- | |-------------------------|-------------| | 日期 | 2024/8/30 | | 当前股价 ( 元 ) | 19.77 | | 一年最高最低 ( 元 ) | 26.02/16.42 | | 总市值 ( 亿元 ) | 19.86 | | 流通市值 ( 亿元 ) | 19.86 | | 总股本 ( 亿股 ) | 1.00 | | 流通股本 ( 亿股 ) | 1.00 | | 近 3 个月换手率 (%) | 35.84 | 股价走势图 -30% -20% -10% 0% 10% 2023-08 2023-12 2024-04 倍加洁 沪深300 数据来源:聚源 相关研究报告 《Q1 需求恢复业绩迎拐点,期待大健 康领域业务表现—公司信息更新报 告》-2024.4.25 《拟出资控股微生物益生菌企业,成 长 性 可 期 — 公 司 信 息 更 新 报 告 ...
倍加洁(603059) - 2024 Q2 - 季度财报
2024-08-27 10:09
Financial Performance - The company's operating revenue for the first half of 2024 reached ¥620,160,522.82, representing a 28.60% increase compared to ¥482,250,410.36 in the same period last year[14]. - The net profit attributable to shareholders of the listed company was ¥33,142,878.09, a decrease of 9.36% from ¥36,566,884.05 in the previous year[14]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥31,482,910.36, down 13.09% from ¥36,223,421.87 in the same period last year[14]. - The net cash flow from operating activities was ¥65,410,112.97, an increase of 24.83% compared to ¥52,400,223.28 in the previous year[16]. - Basic earnings per share for the reporting period (January to June) decreased to 0.33 CNY, down 10.81% from 0.37 CNY in the same period last year[17]. - Diluted earnings per share also fell to 0.33 CNY, reflecting a 10.81% decline compared to the previous year[17]. - The weighted average return on equity decreased to 2.65%, down 0.44 percentage points from 3.09% year-on-year[17]. - The total comprehensive income for the first half of 2024 was ¥32,844,256.20, compared to ¥38,128,847.43 in the first half of 2023[83]. Market Overview - The oral hygiene product market in China is projected to grow at a compound annual growth rate of 3.75% from 2023 to 2028, following a slight decline in 2022 due to the pandemic[19]. - The market size for oral hygiene products in China was 491.5 billion CNY in 2023, recovering from a dip to 482 billion CNY in 2022[19]. - In the first half of 2024, the toothpaste market share reached 47.8%, while the toothbrush market share was 33.4%, together accounting for 81.2% of the oral care industry retail sales[20]. - The online retail sales of mouth spray products increased by 15% year-on-year in the first half of 2024, driven by rising consumer demand for personal image maintenance[20]. - The online retail sales of electric toothbrushes grew by 6.3% year-on-year in the first half of 2024, reflecting consumer preference for efficient cleaning and smart features[20]. Investment and Acquisitions - The company acquired a 52.0006% stake in Shan'enkang, which is now a subsidiary included in the consolidated financial statements[32]. - The company invested ¥6 million to establish a subsidiary in Hangzhou, named Hangzhou Yi Qin[39]. - The company acquired 1.59% equity in Wei Mei Zi for ¥2,531.47 million through a network auction[39]. - The company completed the acquisition of 52.0006% equity in Shen En Kang, which is now included in the consolidated financial statements[39]. Research and Development - The company has over 300 patents and a dedicated R&D team of more than 200 personnel, enhancing its innovation capabilities and industry influence[28]. - The company invested in R&D, with expenses increasing by 48.33% to ¥20,729,096.00, reflecting a commitment to innovation[32]. - The company has established two R&D centers for probiotic products, employing over 40 specialized researchers and holding numerous patents related to probiotics[29]. - The company reported a significant increase in research and development expenses, reflecting a focus on innovation[84]. Financial Position - The total assets at the end of the reporting period were ¥2,263,050,955.97, reflecting a 12.31% increase from ¥2,015,036,620.18 at the end of the previous year[16]. - The net assets attributable to shareholders of the listed company decreased by 11.21% to ¥1,109,064,345.42 from ¥1,249,089,661.23 at the end of the previous year[16]. - Cash and cash equivalents decreased by 14.57% to ¥59,902,878.08, primarily due to significant cash outflows from equity investments[35]. - Total liabilities increased to CNY 1,084,637,018.75 from CNY 765,946,958.95, indicating a growth of about 41.7%[77]. Risk Factors - The company has detailed potential risks in the report, which investors are advised to review[3]. - The company faces risks from fluctuations in raw material prices, particularly those linked to petrochemical products, which could impact profitability[48]. - The company is exposed to risks from market competition, particularly in the probiotics sector, where foreign brands dominate with an 85% market share[48]. - The company is actively expanding its overseas business but faces risks from exchange rate fluctuations and potential reductions in export tax rebate rates[49]. Corporate Governance - The company did not propose any profit distribution plan or capital reserve transfer to increase share capital during the reporting period[3]. - There were no non-operating fund occupations by controlling shareholders or other related parties during the reporting period[3]. - The company has established a knowledge property protection department to safeguard its core technologies and product formulas[49]. - The company has committed to not engaging in any competitive activities with its subsidiaries, ensuring no direct or indirect competition in the same business areas[57]. Compliance and Reporting - The company has maintained compliance with accounting standards, ensuring accurate financial reporting and transparency[99]. - The company has no significant doubts regarding its ability to continue as a going concern for the next 12 months[100]. - The company’s accounting policies are aligned with the relevant financial reporting standards, ensuring consistency in financial statements[101]. - The company follows a control-based approach for consolidating financial statements, including all subsidiaries under its control[107].
倍加洁:关于召开2024年第一次临时股东会的通知
2024-08-27 10:09
证券代码:603059 证券简称:倍加洁 公告编号:2024-035 倍加洁集团股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 一、 召开会议的基本情况 (一) 股东会类型和届次 2024 年第一次临时股东会 召开的日期时间:2024 年 9 月 12 日 14 点 30 分 召开地点:公司 8 号会议室 (五) 网络投票的系统、起止日期和投票时间。 股东会召开日期:2024年9月12日 本次股东会采用的网络投票系统:上海证券交易所股东大会网络投票系 统 (二) 股东会召集人:董事会 (三) 投票方式:本次股东会所采用的表决方式是现场投票和网络投票相结合 的方式 (四) 现场会议召开的日期、时间和地点 网络投票系统:上海证券交易所股东大会网络投票系统 关于召开 2024 年第一次临时股东会的通知 网络投票起止时间:自 2024 年 9 月 12 日 至 2024 年 9 月 12 日 采用上海证券交易所网络投票系统,通过交易系统投票平台的投票时间为股 东会召开当日的交易时间段,即 9:15-9:2 ...
倍加洁:关于2024年半年度主要经营数据的公告
2024-08-27 10:07
证券代码:603059 证券简称:倍加洁 公告编号:2024-036 倍加洁集团股份有限公司 关于 2024 年半年度主要经营数据的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 倍加洁集团股份有限公司(以下简称"公司")根据《上海证券交易所上市 公司自律监管指引第 3 号——行业信息披露 第十三号 化工》有关规定,将公司 2024 年半年度主要经营数据披露如下: 二、主要产品和原材料的价格变动情况 (一)主要产品价格波动情况 单位:元/支、片 | 主要产品 | 2024 | 年半年度 | 2023 | 年半年度 | 变动幅度(%) | | | --- | --- | --- | --- | --- | --- | --- | | | | 均价 | | 均价 | | | | 牙刷 | | 1.177 | | | 1.245 | -5.46 | | 湿巾 | | 0.072 | | | 0.075 | -4.00 | (二)主要原材料价格波动情况 公司主要原材料有刷丝、塑料粒子、无纺布等。 1、刷丝 一、2024 年半年度 ...
倍加洁:倍加洁集团股份有限公司对外投资管理制度(2024年8月修订)
2024-08-27 10:07
第一章 总则 (七)委托理财; (八)其他投资。 倍加洁集团股份有限公司 对外投资管理制度 二零二四年八月修订 倍加洁集团股份有限公司 对外投资管理制度 本制度所称对外投资不包括公司购买原材料、设备和动力,以及出售 产品、商品等与日常经营相关的资产的行为。 1 第一条 为规范倍加洁集团股份有限公司(以下简称"公司")对外投资行为, 强化对外投资管理和监督,控制投资风险,提高投资效益,维护公司 及公司股东的合法利益,根据《中华人民共和国公司法》、《中华人民 共和国证券法》、《上海证券交易所股票上市规则》等有关法律法规、 规范性文件相关规定,结合《倍加洁集团股份有限公司章程》(以下 简称"《公司章程》")及公司实际情况,制定本制度。 第二条 本制度所称对外投资,是指公司为获取未来收益,以公司合法持有的 货币资金、实物、无形资产等资源进行的各种形式的投资活动,包括 但不限于下列行为: (一)新设立企业的股权投资; (二)新增投资企业的增资扩股、股权收购投资; (三)现有投资企业的增资扩股、股权收购投资; (四)公司经营性项目及资产投资; (五)股票、基金投资; (六)债券、委托贷款及其他债权投资; 第三条 本制度适 ...
倍加洁:倍加洁集团股份有限公司2023年年度权益分派实施公告
2024-07-08 09:08
证券代码:603059 证券简称:倍加洁 公告编号:2024-032 差异化分红送转: 否 一、 通过分配方案的股东大会届次和日期 倍加洁集团股份有限公司 2023 年年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 每股分配比例 A 股每股现金红利 0.2 元 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权(息)日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | A股 | 2024/7/12 | - | 2024/7/15 | 2024/7/15 | 截至股权登记日下午上海证券交易所收市后,在中国证券登记结算有限责任公司上海分 公司(以下简称"中国结算上海分公司")登记在册的本公司全体股东。 3. 分配方案: 四、 分配实施办法 二、 分配方案 1. 实施办法 (1)无限售条件流通股的红利委托中国结算上海分公司通过其资金清算系统向股权登记 日上海证券交易所收市后登记在册并在上海证券交易所各会员办理了指定交易的股东派发。 已办理指 ...